Date: September 15, 2021
Read time: 6 minutes
Can I grow cannabis at home?
Medical marijuana patients 18 years and older will be able to grow up to 3 mature and 3 immature plants at home starting October 1, 2021, with a cap of 12 total plants per household. All adults over age 21 will be able to grow under the same rules starting July 1, 2023. Plants must be grown indoors and must not be visible from the street. People who choose to grow their own plants must do so in their primary residence and where individuals under 21 can not access the plants.
Besides the challenges of growing a sufficient amount of high-quality cannabis for a rapidly growing market, cannabis companies have to deal with something that illegal growers do not — government regulation.
Part of Nature Outlook: Cannabis
To run these advanced facilities, cannabis companies need researchers who are experienced in plant science, microbiology, chemistry and other scientific disciplines — and they are turning to academia to find them. “Instead of underground growers, they are hiring lots of university-educated and trained people,” says Zheng.
One sign of progress is that cannabis products can be recalled when they fail testing, just like other medical or consumer items. In December 2016 and January 2017, Organigram had to recall some of its products when residues from pesticides not approved for use in cannabis were detected. Although the company’s reputation took a short-term hit, Purcell says that recalls are a sign of the industry’s growing professionalism. Consumers can be confident that cannabis goods have been made “under a controlled, regulated environment and tested in a certified lab that guarantees safety and quality”.
The large-scale, controlled environment enables Organigram to conduct systematic, controlled trials and to produce huge amounts of data — with 5 cycles of growth per year in each of the growing rooms, it can generate more than 250 generations’ worth of growing data each year, says Purcell. The company can use those data to determine what works best for the plants, and then replicate those conditions at scale. “That’s the big difference with the black market,” he says. “When you scale up, you have to take a data-driven approach.”
More from Nature Outlooks
Cannabis analytical labs are becoming more professional. “I’ve seen an evolution in the sophistication of the industry,” Brauninger says. “Most of the people running labs now have PhDs and experience in the pharmaceutical industry. It’s light years more sophisticated than five or six years ago.”